| Dr Thomas Joseph Jantos, MD | |
|
2170 South Ave, South Lake Tahoe, CA 96150-7026 | |
| (530) 541-3420 | |
| Not Available |
| Full Name | Dr Thomas Joseph Jantos |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 2170 South Ave, South Lake Tahoe, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639176415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 9173 (Nevada) | Secondary |
| 207P00000X | Emergency Medicine | A62096 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carson Valley Medical Center | Gardnerville, NV | Hospital |
| Barton Memorial Hospital | South lake tahoe, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tahoe Emergency Physicians Medical Corporation | 0446151674 | 14 |
News Archive
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).
Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer.
Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them. In the ACS journal Langmuir, scientists are reporting new understanding about the dynamics of 3-D bioprinting that takes them a step closer to realizing their goal of making working tissues and organs on-demand.
Niusule Biotech Corp., a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
› Verified 2 days ago
| Entity Name | Tahoe Emergency Physicians Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104937408 PECOS PAC ID: 0446151674 Enrollment ID: O20040120000328 |
News Archive
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).
Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer.
Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them. In the ACS journal Langmuir, scientists are reporting new understanding about the dynamics of 3-D bioprinting that takes them a step closer to realizing their goal of making working tissues and organs on-demand.
Niusule Biotech Corp., a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
› Verified 2 days ago
| Entity Name | Barton Healthcare System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235196015 PECOS PAC ID: 1850293960 Enrollment ID: O20040915000806 |
News Archive
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).
Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer.
Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them. In the ACS journal Langmuir, scientists are reporting new understanding about the dynamics of 3-D bioprinting that takes them a step closer to realizing their goal of making working tissues and organs on-demand.
Niusule Biotech Corp., a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Joseph Jantos, MD 1111 Emerald Bay Rd, South Lake Tahoe, CA 96150-6207 Ph: (530) 543-5979 | Dr Thomas Joseph Jantos, MD 2170 South Ave, South Lake Tahoe, CA 96150-7026 Ph: (530) 541-3420 |
News Archive
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).
Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer.
Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them. In the ACS journal Langmuir, scientists are reporting new understanding about the dynamics of 3-D bioprinting that takes them a step closer to realizing their goal of making working tissues and organs on-demand.
Niusule Biotech Corp., a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
› Verified 2 days ago
Michael Corbin Schankerman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Michael R Mclaughlin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Dr. Amy Pape Anton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Dr. Taylor Brooke Myatt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Dr. Kandra T Yee, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Dr. Michael E. R. Habicht, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 | |
Dr. Clinton James Masterson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2170 South Ave, South Lake Tahoe, CA 96150 Phone: 530-541-3420 |